You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 30, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
1Richard Pullen is a professor at the Texas Tech University Health Sciences Center and is a member of the Nursing2024 editorial board.
Bladder cancer, a common urothelial cell carcinoma, arises from genetic mutations and predispositions. Understanding risk factors, symptoms, and treatments is crucial for effective patient care and education.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: